ICSI for treatment of human immunodeficiency virus and hepatitis C virus-serodiscordant couples with infected male partner

Hum Reprod. 2005 Aug;20(8):2242-6. doi: 10.1093/humrep/dei031. Epub 2005 Jun 9.

Abstract

Background: Assisted reproductive technology with semen washing can offer a significant reduction in risk of sexual and vertical transmission of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) in serodiscordant couples with infected male partner.

Methods: Among couples coming to our centre for reproductive problems from January 2001 to December 2003, we selected 43 couples with seropositive male and seronegative female: 25 couples with HIV-seropositive males, 10 couples with HIV/hepatitis C virus (HCV)-seropositive males and eight couples with HCV-seropositive males. Sperm samples were washed and used for ICSI.

Results: Seventy-eight cycles of ICSI were performed. The mean fertilization rate was 70.34 +/- 20.14% (mean +/- SD). A mean number of 3.55 +/- 1.11 (range: 1-5) embryos of good quality was transferred for each patient. We obtained 22 pregnancies (21 singletons and one twin), with a pregnancy rate per transfer of 28.2% and an implantation rate per transfer of 15.2%. The cumulative pregnancy rate was 51.2%. At follow-up, no seroconversion was detected in any patient.

Conclusions: Our data suggest that sperm wash and ICSI could be useful for reducing the risk of HIV and/or HCV transmission in serodiscordant couples with infected male wishing to have a child, irrespective of their fertility status.

MeSH terms

  • Adult
  • Female
  • Fertility
  • Follow-Up Studies
  • HIV Infections / epidemiology
  • HIV Infections / prevention & control*
  • HIV Infections / transmission*
  • HIV Seropositivity
  • Hepatitis C, Chronic / epidemiology
  • Hepatitis C, Chronic / prevention & control*
  • Hepatitis C, Chronic / transmission*
  • Humans
  • Male
  • Pregnancy
  • Pregnancy Outcome
  • Risk Factors
  • Sperm Injections, Intracytoplasmic*
  • Spermatozoa / virology